Article No
ANC-174-040
Application | FC, IHC |
Article No | ANC-174-040 |
Country Availability | SE, FI, DK, NO, IS, EE, LV, LT |
Clone | 7G7B6 |
Clone Type | monoclonal |
Conjugation | FITC |
Description | anti-CD25 (human), mAb (7G7B6) (FITC) |
Supplier | Adipogen Life Sciences |
Format | Liquid |
Immunogen | Stimulated PBMC. |
Isotype | IgG2a |
Notes | Expression of human CD25 (the alpha subunit of the IL-2 receptor complex) is dramatically upregulated on activated T cells, B cells, NK cells and macrophages. Antibodies to CD25 are being studied for potential use as an immunodirected therapy to selectively attack (kill) CD25 expressing cells.|Monoclonal Antibody. Isotype: Mouse IgG2a. Clone: 7G7B6. Applications: FACS, IHC. 50 mM Sodium Phosphate pH 7.5, 100 mM Potassium Chloride, 150mM NaCl, 5% Glycerol, 0.2% BSA, 0.04% NaN3 (as a preservative). Expression of human CD25 (the alpha subunit of the IL-2 receptor complex) is dramatically upregulated on activated T cells, B cells, NK cells and macrophages. Antibodies to CD25 are being studied for potential use as an immunodirected therapy to selectively attack (kill) CD25 expressing cells. |
Alias Names | IL-2 Receptor Subunit alpha; IL-2-RA; TAC Antigen; p55 |
Product Type | Antibodies Primary |
Research area | Immunology |
Shipping Information | BLUE ICE |
Size | 120 tests |
Source / Host | mouse |
Species Reactivity | human |
Stability | Stable for at least 1 year after receipt when stored at +4°C. |
Storage | 4°C |
Substrate / Buffer | 50 mM Sodium Phosphate pH 7.5, 100 mM Potassium Chloride, 150mM NaCl, 5% Glycerol, 0.2% BSA, 0.04% NaN3 (as a preservative). |
Technical Specifications | Monoclonal Antibody. Isotype: Mouse IgG2a. Clone: 7G7B6. Applications: FACS, IHC. 50 mM Sodium Phosphate pH 7.5, 100 mM Potassium Chloride, 150mM NaCl, 5% Glycerol, 0.2% BSA, 0.04% NaN3 (as a preservative). Expression of human CD25 (the alpha subunit of the IL-2 receptor complex) is dramatically upregulated on activated T cells, B cells, NK cells and macrophages. Antibodies to CD25 are being studied for potential use as an immunodirected therapy to selectively attack (kill) CD25 expressing cells. |
Product Page Updated | 2024-02-01T08:25:01.492Z |